Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

The role of micronutrients in the risk of urinary tract cancer.

Golabek T, Bukowczan J, Sobczynski R, Leszczyszyn J, Chlosta PL.

Arch Med Sci. 2016 Apr 1;12(2):436-47. doi: 10.5114/aoms.2016.59271.

2.

Potent inhibitory effect of δ-tocopherol on prostate cancer cells cultured in vitro and grown as xenograft tumors in vivo.

Huang H, He Y, Cui XX, Goodin S, Wang H, Du ZY, Li D, Zhang K, Tony Kong AN, DiPaola RS, Yang CS, Conney AH, Zheng X.

J Agric Food Chem. 2014 Nov 5;62(44):10752-8. doi: 10.1021/jf504058f.

3.

Vitamin E: a dark horse at the crossroad of cancer management.

Cardenas E, Ghosh R.

Biochem Pharmacol. 2013 Oct 1;86(7):845-52. doi: 10.1016/j.bcp.2013.07.018. Review.

4.

High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate.

Sekine Y, Osei-Hwedieh D, Matsuda K, Raghavachari N, Liu D, Furuya Y, Koike H, Suzuki K, Remaley AT.

Prostate. 2011 Oct 1;71(14):1499-509. doi: 10.1002/pros.21365.

5.

Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.

Ledesma MC, Jung-Hynes B, Schmit TL, Kumar R, Mukhtar H, Ahmad N.

Mol Med. 2011 Jan-Feb;17(1-2):134-43. doi: 10.2119/molmed.2010.00136. Review.

6.

Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.

Lindshield BL, Ford NA, Canene-Adams K, Diamond AM, Wallig MA, Erdman JW Jr.

PLoS One. 2010 Apr 29;5(4):e10423. doi: 10.1371/journal.pone.0010423.

7.

Cancer-preventive activities of tocopherols and tocotrienols.

Ju J, Picinich SC, Yang Z, Zhao Y, Suh N, Kong AN, Yang CS.

Carcinogenesis. 2010 Apr;31(4):533-42. doi: 10.1093/carcin/bgp205. Review.

8.

Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer.

Patel MI, Singh J, Niknami M, Kurek C, Yao M, Lu S, Maclean F, King NJ, Gelb MH, Scott KF, Russell PJ, Boulas J, Dong Q.

Clin Cancer Res. 2008 Dec 15;14(24):8070-9. doi: 10.1158/1078-0432.CCR-08-0566.

9.

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr.

JAMA. 2009 Jan 7;301(1):39-51. doi: 10.1001/jama.2008.864.

10.

Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells.

Gundimeda U, Schiffman JE, Chhabra D, Wong J, Wu A, Gopalakrishna R.

J Biol Chem. 2008 Dec 12;283(50):34519-31. doi: 10.1074/jbc.M807007200.

11.

Dietary terpenoids and prostate cancer chemoprevention.

Rabi T, Gupta S.

Front Biosci. 2008 May 1;13:3457-69.

12.

Resveratrol-induced gene expression profiles in human prostate cancer cells.

Jones SB, DePrimo SE, Whitfield ML, Brooks JD.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):596-604.

Supplemental Content

Support Center